(Total Views: 539)
Posted On: 07/08/2024 4:24:23 PM
Post# of 155843
I think that study was focused on patients with MASH/NASH and poorly controlled Type 2 Diabetes (T2D).
This is their MASH phase 2b trial results.
https://www.nejm.org/doi/full/10.1056/NEJMoa2036205
This is their MASH phase 2b trial results.
https://www.nejm.org/doi/full/10.1056/NEJMoa2036205
(1)
(0)
